Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-26

FDA Approved: TEMAZEPAM — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved Ascend Laboratories' supplemental application for Temazepam (generic) under ANDA071456, authorizing the marketed Temazepam product. This repres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Temazepam (Temazepam)

Snippet

SUPPL AP for TEMAZEPAM (TEMAZEPAM)